[Student's mental health: better measurement and considereration of the challenges].

La santé mentale des étudiants : mieux prendre la mesure et considérer les enjeux.
Depression Dépression Etudiants Measures Mental health Mesures Methodology Méthodologie Santé mentale Students

Journal

L'Encephale
ISSN: 0013-7006
Titre abrégé: Encephale
Pays: France
ID NLM: 7505643

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 01 08 2020
revised: 13 10 2020
accepted: 30 10 2020
pubmed: 23 3 2021
medline: 15 12 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

Mental health represents a high cost for society, estimated at 109 billion euros per year in France, 80 % of which are indirect costs. Mental diseases start before the age of 24 for 75 % of patients. Students, whose age is predominantly between 18 and 25, are a particularly high-risk population and for whom mental illness can have very serious consequences. The Observatoire de la vie Etudiante surveys from 2016 found a 12 month prevalence of depression of 15 % with suicidal thoughts in 8 % of the students higher than what is observed in the French general population, respectively 10 % and 5 %. The confinement itself and its consequences both economic (unemployment, difficulty for young people to find a job…) and social (isolation) could have a very bad effect on their mental health. The survey made by a governmental organization (Santé Publique France) revealed a significant increase in the prevalence of anxiety disorders at the start of confinement in the general population. This prevalence decreased during confinement but remained significantly higher than in 2017. Economic simulated data indicate that prevention in mental health could not only be effective but also profitable. In France, reimbursement by national health insurance of 12 sessions of psychologists for young people (between 11 to 21) is being tested in order to further and widely implement psychological prevention strategies rather than relying on already widely reimbursed pharmacological treatments. There are, however, several issues to discuss. First of all, is the need to define what psychopathology is considered to be. Then, it should be understood how measures of these concepts are created, how tools are constructed and how they operate in their environment. For depression, many different scales exist and even if the most used one are taken into account, they have very little content or symptoms in common. In addition, for the same scale, many different cut-offs exist to define whether a case should be considered as pathological or not, and so it is with the period of time studied being considered that may vary, both leading to consequences such as the differences observed in prevalence. Other biases should also be considered such as the age of the participants, the gender, the size of the sample, the response rate, the method of assessment and recruitment. Finally, it is necessary to question the assumptions and models used concerning the causes of psychic pathologies. Biological hypotheses on the origin of depression involve genetics and inflammation, but sociological and psychological factors must also be considered as well as the underlying complexity both in their nature and interactions at different structural levels of space and time. We should avoid drifting towards a biological or a sociological reductionism and move forward through complex systems approaches and models. With regard to student mental health in France, unfortunately, quality data are still lacking, and existing studies are difficult to compare as some may also have methodological issues. This article leads to the conclusion that there is a need for policies to assess student mental health at both local and national levels with a reflexional thinking on the tools and scales to use as measurements of these phenomena. This approach does not require being too assertive, but should have full transparency on the way the measures were designed and obtained. Measures are as much needed as are the needs for coordinated prevention and care in mental health.

Identifiants

pubmed: 33745696
pii: S0013-7006(21)00035-X
doi: 10.1016/j.encep.2020.10.009
pmc: PMC7972866
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

620-629

Informations de copyright

Copyright © 2021 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.

Références

PLoS One. 2015 Sep 14;10(9):e0137621
pubmed: 26368008
Annu Rev Clin Psychol. 2018 May 7;14:1-28
pubmed: 29328780
Lancet Psychiatry. 2017 Feb;4(2):146-158
pubmed: 27856392
JAMA Psychiatry. 2020 Feb 1;77(2):155-164
pubmed: 31746968
BMC Med. 2020 Jul 14;18(1):205
pubmed: 32660482
Early Interv Psychiatry. 2010 May;4(2):132-42
pubmed: 20536969
Nat Hum Behav. 2020 Nov;4(11):1092-1094
pubmed: 33037396
Am J Psychiatry. 2003 Jan;160(1):4-12
pubmed: 12505793
JAMA Psychiatry. 2021 Jan 1;78(1):110-112
pubmed: 32725176
J Affect Disord. 2017 Jan 15;208:191-197
pubmed: 27792962
J Child Psychol Psychiatry. 2021 Aug;62(8):1032-1036
pubmed: 32986859
Lancet Psychiatry. 2020 Jul;7(7):567-568
pubmed: 32502467
Soc Psychiatry Psychiatr Epidemiol. 2010 Feb;45(2):189-99
pubmed: 19381424
Lancet Psychiatry. 2020 Jun;7(6):479-480
pubmed: 32445681
JAMA. 2016 Dec 6;316(21):2214-2236
pubmed: 27923088
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Behav Brain Sci. 2018 Jan 24;42:e2
pubmed: 29361992
JAMA Psychiatry. 2020 Nov 1;77(11):1095-1096
pubmed: 32579156
Nature. 2020 Jun;582(7813):482-484
pubmed: 32581374
Perspect Psychol Sci. 2021 Jul;16(4):756-766
pubmed: 33593167
Assessment. 2016 Aug;23(4):447-458
pubmed: 27165092

Auteurs

Y Morvan (Y)

Université Paris Nanterre, UFR SPSE, laboratoire CLIPSYD, EA4430, Nanterre, France; Inserm U1018, CESP, épistémologie et méthodes de la recherche en pédopsychiatrie et santé mentale des enfants et des adolescents, Paris, France. Electronic address: ymorvan@parisnanterre.fr.

A Frajerman (A)

Inserm U1266-GDR 3557, institut de psychiatrie et neurosciences de Paris, institut de Psychiatrie, Paris, France; Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH